What a SIBO Breath Test Can and Can't Tell You

How the Test Actually Works

A SIBO breath test gives you a sugar substrate — usually lactulose or glucose — then measures the hydrogen and methane in your breath every 15 to 20 minutes for two to three hours. Bacteria in the small intestine ferment that sugar and produce gas that diffuses into the blood and out through the lungs; a rise crossing a set threshold within a defined time window counts as positive.

The American College of Gastroenterology defines SIBO (small intestinal bacterial overgrowth) as an excess of bacteria in the small intestine producing GI symptoms, and its 2020 clinical guideline addresses breath testing directly, including where the method runs into trouble 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Defines SIBO and supports statements on breath-test diagnosis, its limitations (transit-time effects, threshold variability, methane under-detection), and the conditional recommendation for antibiotic treatment of a symptomatic positive result.. The test's appeal is straightforward: it is noninvasive, far cheaper than sampling the small intestine directly, and does not require sedation or a procedure. That convenience is exactly why it has become the default diagnostic tool for suspected SIBO, even though it was never built to be a precise one. A related but separate approach, the hydrogen breath test lactose uses to check for lactose intolerance, runs on the same basic chemistry but answers a completely different question: whether one specific sugar is being digested at all, not whether bacteria are overgrown.

Why a Positive Result Isn't Always SIBO

A positive breath test does not prove bacterial overgrowth on its own, because the two things it actually measures — how fast gas rises and how high it climbs — can be thrown off by how quickly food moves through the gut, not just by how much bacteria are fermenting it.

People with rapid intestinal transit can produce an early, robust gas rise simply because the test sugar reaches the colon faster than expected, where fermentation is normal rather than pathological. The test has no way to tell the difference between sugar that arrived in the colon early and sugar fermented by bacteria that should not be in the small intestine at all. Recent meals, smoking before the test, and even how someone breathes into the collection device can shift results. Add to that the fact that different labs use different positivity thresholds and different time windows, and the same person's gas curve could be read as positive at one center and negative at another. The ACG guideline flags these limitations directly as part of its recommendations on how, and how cautiously, to interpret a result 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Defines SIBO and supports statements on breath-test diagnosis, its limitations (transit-time effects, threshold variability, methane under-detection), and the conditional recommendation for antibiotic treatment of a symptomatic positive result..

Why a Negative Result Isn't Always Reassuring

A negative breath test does not rule SIBO out either, largely because standard tests built around hydrogen alone miss a meaningful share of cases that are driven by methane-producing organisms instead.

Some people harbor archaea, methane-producing organisms rather than bacteria in the strict sense, that consume hydrogen as fast as it is made, flattening the hydrogen curve even when overgrowth is present. Testing both gases catches more of these cases, but not every lab offers dual-gas testing, and the guideline calls for testing methane specifically because relying on hydrogen alone under-detects it 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Defines SIBO and supports statements on breath-test diagnosis, its limitations (transit-time effects, threshold variability, methane under-detection), and the conditional recommendation for antibiotic treatment of a symptomatic positive result.. Timing is another blind spot: overgrowth further down the small intestine, closer to where the colon begins, can produce a gas rise late enough to be mistaken for normal colonic fermentation and read as negative. A negative test with ongoing symptoms is common, and it does not mean nothing is wrong — it means the test did not answer the question, which is a different thing.

Why There's No Perfect Test to Check It Against

Breath testing is judged against an imperfect reference standard, because the only way to directly confirm small intestinal bacterial overgrowth, sampling and culturing fluid from the small intestine during endoscopy, is invasive, inconsistently performed, and has known accuracy problems of its own.

Jejunal aspirate and culture is the closest thing to a gold standard, but it requires reaching well past where a standard upper endoscopy stops, carries contamination risk during collection, and different labs use different bacterial-count cutoffs to call a sample positive. When the reference test itself is imperfect, no single accuracy percentage attached to the breath test can be fully trusted; it is being measured against a flawed ruler. A methodology paper on grading diagnostic evidence makes a broader, useful point here: a test's real value does not come from its accuracy number in isolation, but from whether acting on the result changes what happens next for the patient, and whether that change does more good than harm 2Ref 2Schünemann HJ, Oxman AD, Brozek J, et al. (2008).Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.Supports the framing that a diagnostic test's value depends on the downstream consequences of acting on true and false positive and negative results, not on its accuracy percentage alone.. For SIBO breath testing, that reframes the right question from how accurate this is, exactly, to whether a positive result leads somewhere useful.

Testing for h. pylori runs into a related but different accuracy puzzle: it uses a urea-based breath test that looks for a specific bacterial enzyme rather than fermentation gas, so it is not vulnerable to the same transit-time problem, a reminder that not every breath test shares the same weaknesses.

What a Positive Result Should Actually Trigger

A positive SIBO breath test is usually treated as one input toward a trial of antibiotic therapy, not as a final diagnosis to keep re-testing until the number looks perfect.

The ACG guideline conditionally recommends antibiotic treatment for symptomatic patients with a positive breath test, weighing the modest quality of the underlying evidence against the burden of leaving symptoms untreated 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Defines SIBO and supports statements on breath-test diagnosis, its limitations (transit-time effects, threshold variability, methane under-detection), and the conditional recommendation for antibiotic treatment of a symptomatic positive result.. Rifaximin is the antibiotic most studied for gut symptoms broadly: in the phase 3 TARGET trials, a two-week course produced a modest but statistically significant improvement in global symptoms and bloating compared with placebo, in people with IBS without constipation 3Ref 3Pimentel M, Lembo A, Chey WD, et al. (TARGET Study Group) (2011).Rifaximin therapy for patients with irritable bowel syndrome without constipation.Supports the reported effect size of a two-week rifaximin course on global symptoms and bloating in IBS without constipation, as the closest available large-scale evidence for this drug class; does not cover IBS-C.. That trial was not testing SIBO directly and does not cover IBS with constipation, but it is the closest large-scale evidence available for how this drug class performs on the same symptoms SIBO testing is chasing. The practical pattern many clinicians use is symptom-based rather than number-based: if bloating, diarrhea, or discomfort improve after treatment, that response matters more than whether a repeat breath test normalizes.

When the Symptom Picture Matters More Than the Test

For many people with chronic bloating, gas, or altered bowel habits, the more useful path skips the breath test's uncertainty and asks instead whether the symptoms simply meet the criteria for irritable bowel syndrome.

The current ACG guideline for IBS recommends a positive diagnostic strategy, confirming IBS by its own symptom pattern, rather than treating it as a diagnosis of exclusion reached only after ruling out everything else, including SIBO 4Ref 4Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Supports that current guidance favors a positive diagnostic strategy for IBS rather than diagnosis reached only by excluding other conditions.. Those symptom criteria come from the Rome IV framework, which defines IBS by recurrent abdominal pain tied to changes in bowel habits over a defined period 5Ref 5The Rome Foundation (2016).Rome IV Criteria.Supports that IBS is defined by Rome IV symptom-based criteria, requiring recurrent abdominal pain tied to a change in bowel habits.. Because IBS and SIBO symptoms overlap so heavily, bloating, gas, unpredictable bowel habits, untangling is it ibs or sibo is one of the most common follow-up questions once a breath test comes back positive or ambiguous, and it is worth its own answer rather than a quick guess. What SIBO actually is beyond a breath test result, and how confidently it can be diagnosed at all, is its own subject: small intestinal bacterial overgrowth definition and the honest state of the evidence live there. And for the mechanics of the appointment itself, what to eat beforehand and how the collection goes, sibo breath test what to expect covers that ground separately.